Stay updated on Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added downloadable documents for the study (Statistical Analysis Plan and Study Protocol) along with metadata, and updated record dates and related keywords to reflect current documentation for the trial.
    Difference
    100%
    Check dated 2026-10-01T15:20:11.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden message with a simple header and a Home link, and previously available study content and documents are removed; navigation remains possible but the study information is no longer accessible.
    Difference
    18%
    Check dated 2026-09-24T18:35:43.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page metadata now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a non-content update to the site/template rather than changes to the study data.
    Difference
    0.0%
    Check dated 2026-09-17T22:52:30.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    A funding source entry for NIH grant/contract was added to the study record. This reflects NIH support for the trial.
    Difference
    0.0%
    Check dated 2026-08-27T18:18:42.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This is a metadata-level update to the page template and does not alter study content or functionality.
    Difference
    0.0%
    Check dated 2026-08-06T23:08:54.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    A new citation for Lenvatinib plus pembrolizumab outcomes (KEYNOTE-775/LEAP-001) has been added to the Publications section, listing the authors and journal details. The previous 'Online ahead of print' note has been removed.
    Difference
    0.0%
    Check dated 2026-07-30T19:11:35.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo With Pembrolizumab in Endometrial Cancer Clinical Trial page.